Johnson and Johnson Corporate Integrity Agreement: The Progression of Life…
Compliance managers at pharmaceutical companies and medical device manufacturers can stay ahead of enforcement trends by…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
November 2013
Physician Payment Sunshine Act: CMS to Host Education for Company…
According to a release from the Centers for Medicare & Medicaid Services (CMS), in response to stakeholder requests, on…
FDA Draft National Adverse Event Plan
Adverse drug events (ADEs) have been defined as an injury resulting from medical intervention related to a drug. ADEs can occur in…
Health Leaders Call for Reformation of the Physician Certification Process
A recent post at Health Affairs blog calls for reforming the physician certification process. It is authored by Dr. Alan Muney,…
FDA: A Parents’ Guide to Kids’ Vaccines
The FDA has unveiled a "A Parents' Guide to Kids' Vaccines" on its website. The website outlines several key areas:…
FDA to Launch Program Alignment Group to Define Roles and Responsibilities…
According to Regulatory Focus, in response to "unparalleled challenges" posed by advances in science, globalization and product…
HHS OIG Reports CMS Not Catching All Overpayments
As reported by FierceHealth, a recent report by the Office of Inspector General claimed the Centers for Medicare &…
Johnson and Johnson 2013 Settlement and Corporate Integrity Agreement
On November 4, 2013, the Department of Justice (DOJ) announced that Johnson & Johnson (J&J) and its pharmaceutical…
HITECH HIPAA Restrictions on Refill Reminders and Patient Communications
In late January of this year, we reported that the U.S. Department of Health & Human Services (HHS) issued four…
AAFP Postpones NP and PA Membership
The American Academy of Family Physicians (AAFP) recently announced its intent to study whether nurse practitioners…